Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             74 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors Biedermann, Bjoern
 2007
 31 Supplement 3 p. 211-220
10 p.
 artikel
2 Apoptosis of T-leukemia and B-myeloma cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPK Chen, Yen-Chen
 2007
 31 Supplement 3 p. 805-815
11 p.
 artikel
3 Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1 Qian, Wenbin
 2007
 31 Supplement 3 p. 329-339
11 p.
 artikel
4 Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cells Faderl, Stefan
 2007
 31 Supplement 3 p. 91-95
5 p.
 artikel
5 Author Index 2007
 31 Supplement 3 p. S147-S155
9 p.
 artikel
6 Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines Choi, Cheol-Hee
 2007
 31 Supplement 3 p. 1267-1276
10 p.
 artikel
7 C031 Allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndromes 50 years or older. A retrospective survey from the European Group for Blood and MarrowTransplantation Lim, Z.Y.
 2007
 31 Supplement 3 p. S39-S40
2 p.
 artikel
8 C003 A molecular classification of leukaemia reveals MDS as a disease continuum with non-leukaemia and AML sub groups Gilkes, A.F.
 2007
 31 Supplement 3 p. S24-
1 p.
 artikel
9 Cancer testis/germline antigens (CT/CG-antigens) in leukemias Greiner, Jochen
 2007
 31 Supplement 3 p. 1-3
3 p.
 artikel
10 C017 Animal model of mitochondrial dysfunction generating macrocytic anemia and myelodysplastic bone marrow failure Thompson, J.E.
 2007
 31 Supplement 3 p. S31-S32
2 p.
 artikel
11 Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia Fiegl, Michael
 2007
 31 Supplement 3 p. 531-539
9 p.
 artikel
12 Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production Sancho, Pilar
 2007
 31 Supplement 3 p. 969-978
10 p.
 artikel
13 Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders Lorand-Metze, Irene
 2007
 31 Supplement 3 p. 147-155
9 p.
 artikel
14 Editorial Board 2007
 31 Supplement 3 p. CO2-
1 p.
 artikel
15 Editorial Board 2007
 31 Supplement 3 p. CO2-
1 p.
 artikel
16 Editorial Board 2007
 31 Supplement 3 p. CO2-
1 p.
 artikel
17 E13 Non-Hodgkin lymphoma: how to proceed Aurer, I.
 2007
 31 Supplement 3 p. S23-S25
3 p.
 artikel
18 Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project McKoy, June M.
 2007
 31 Supplement 3 p. 599-604
6 p.
 artikel
19 Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload Gattermann, Norbert
 2007
 31 Supplement 3 p. S10-S15
6 p.
 artikel
20 High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma Bishton, M.
 2007
 31 Supplement 3 p. 1063-1068
6 p.
 artikel
21 ‘Idiopathic’ eosinophilia with an Occult T-cell clone: Prevalence and clinical course Vaklavas, C.
 2007
 31 Supplement 3 p. 691-694
4 p.
 artikel
22 Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg Annabi, Borhane
 2007
 31 Supplement 3 p. 1277-1284
8 p.
 artikel
23 β2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid Wu, Jamie J.
 2007
 31 Supplement 3 p. 49-57
9 p.
 artikel
24 In vitro generation of tumor specific T cells that recognize a shared antigen of AML: Molecular characterization of TCR genes Coppage, Myra
 2007
 31 Supplement 3 p. 195-202
8 p.
 artikel
25 Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells Yang, Sheng-Huei
 2007
 31 Supplement 3 p. 1413-1420
8 p.
 artikel
26 Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia Schimmel, Kirsten J.M.
 2007
 31 Supplement 3 p. 1545-1551
7 p.
 artikel
27 Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells Ikezoe, Takayuki
 2007
 31 Supplement 3 p. 673-682
10 p.
 artikel
28 OP25 Current therapy for ALL in adults Hoelzer, D.
 2007
 31 Supplement 3 p. S44-S45
2 p.
 artikel
29 OP15 Front-line treatment of acute promyelocytic leukemia: the state of the art Sanz, M.A.
 2007
 31 Supplement 3 p. S39-S40
2 p.
 artikel
30 OP39 Mechanisms of graft-versus-leukaemia reactions (GvL) in chimeras Kolb, H.J.
 2007
 31 Supplement 3 p. S50-S51
2 p.
 artikel
31 OP56 Rituximab maintenance treatment in follicular lymphoma Hagenbeek, A.
 2007
 31 Supplement 3 p. S59-
1 p.
 artikel
32 OP01 Treatment of acute leukemia: 50 years later Freireich, E.
 2007
 31 Supplement 3 p. S31-
1 p.
 artikel
33 OP42 Update on CML therapy with imatinib, and treatment outcome monitoring Talpaz, M.
 2007
 31 Supplement 3 p. S52-
1 p.
 artikel
34 P057 Abrogation of the DNA-damage response in AML versus MDS cell lines Boehrer, S.
 2007
 31 Supplement 3 p. S71-
1 p.
 artikel
35 P043 Activated monocytes contribute to bone marrow failure in myelodysplastic syndromes Meers, S.
 2007
 31 Supplement 3 p. S64-
1 p.
 artikel
36 P094 Autologous blood stem cell (PBSCT) vs bone marrow transplantation (ABMT) for acute myeloid leukaemia in 1st remission Duraković, N.
 2007
 31 Supplement 3 p. S106-
1 p.
 artikel
37 P091 B7-H1 molecules on blasts in myelodysplastic syndromes Kondo, A.
 2007
 31 Supplement 3 p. S89-
1 p.
 artikel
38 P088 Challenging diagnosis of refractory anemia (RA) and refractory anemia with ringed sideroblasts (RARS): detection of myeloid dysplasia by flow cytometry (FC) Font, P.
 2007
 31 Supplement 3 p. S87-S88
2 p.
 artikel
39 P002 Clinical and epidemiological considerations on myelodysplastic syndromes (MDS). The experience of the Piedmont MDS Register Gioia, D.
 2007
 31 Supplement 3 p. S41-S42
2 p.
 artikel
40 P036 Clinical data of CLL patients with unmutated IGHV1-69 gene expression Abramenko, I.
 2007
 31 Supplement 3 p. S81-
1 p.
 artikel
41 P091 Cord blood banking in Croatia Golubić-Ćepulić, B.
 2007
 31 Supplement 3 p. S105-
1 p.
 artikel
42 P132 Cost of transfusion dependency among managed care patients with myelodysplastic syndromes Frytak, J.R.
 2007
 31 Supplement 3 p. S111-S112
2 p.
 artikel
43 P146 Disease progression in del (5q) MDS patients treated with lenalidomide: analysis of risk factors and long-term outcome in 44 patients Giagounidis, A.A.N.
 2007
 31 Supplement 3 p. S120-S121
2 p.
 artikel
44 P060 Effect of azacitidine on PI-PLC-beta1 expression and Akt activation in a patient affected by high-risk myelodysplastic syndrome (MDS) Finelli, C.
 2007
 31 Supplement 3 p. S72-S73
2 p.
 artikel
45 Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 Mancini, Manuela
 2007
 31 Supplement 3 p. 979-987
9 p.
 artikel
46 P022 Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy Abou Samra, N.
 2007
 31 Supplement 3 p. S74-
1 p.
 artikel
47 P016 Features of secondary myelodysplastic syndrome in persons who suffered from Chornobyl accident Dyagil, I.
 2007
 31 Supplement 3 p. S49-
1 p.
 artikel
48 P019 JAK2 V617F and FLT3 ITD mutation in myelodysplastic syndrome Radić Antolic, M.
 2007
 31 Supplement 3 p. S73-
1 p.
 artikel
49 P063 Mechanisms of action of rituximab and its effectiveness in high risk patients with aggressive CD20+ lymphoma Jezersek Novaković, B.
 2007
 31 Supplement 3 p. S93-
1 p.
 artikel
50 P074 Molecular cytogenetic delineation of del (4q) in myelodysplastic syndromes with peripheral blood monocytosis La Starza, R.
 2007
 31 Supplement 3 p. S80-
1 p.
 artikel
51 PO017 Deferiprone is useful in blood Russolillo, S.
 2007
 31 Supplement 3 p. S137-
1 p.
 artikel
52 PO020 Primary MDS: analysis of survival and risk of leukemia transformation according to FAB, WHO, IPSS and WPSS classifications Velloso, E.R.P.
 2007
 31 Supplement 3 p. S138-S139
2 p.
 artikel
53 PO003 Unrecognised coexistent myelodysplasia as a cause of poor prognosis multiple myeloma Várkonyi, J.
 2007
 31 Supplement 3 p. S130-
1 p.
 artikel
54 P005 Prognostic significance of the different multidrug resistance proteins co-expression in acute myeloid leukemia Zakharov, O.
 2007
 31 Supplement 3 p. S67-
1 p.
 artikel
55 P050 Susceptibility of non-Hodgkin's lymphoma associated with polymorphic variants in folate pathway genes Kim, H.J.
 2007
 31 Supplement 3 p. S87-
1 p.
 artikel
56 P077 The abeyance or initial drastic tratment in mycosis fungoides variants Gaman, G.
 2007
 31 Supplement 3 p. S98-S99
2 p.
 artikel
57 P060 The influence of international prognostic score and bulky disease in patients with primary mediastinal B sclerosing lymphoma treated with immunochemotherapy Mihaljevic, B.
 2007
 31 Supplement 3 p. S91-
1 p.
 artikel
58 P119 The integration of comorbidity in decision making in myelodysplastic syndromes Stauder, R.
 2007
 31 Supplement 3 p. S104-
1 p.
 artikel
59 P105 The number of red blood cell transfusions is a significant but not an independent factor affecting survival in early MDS patients Cermak, J.
 2007
 31 Supplement 3 p. S96-S97
2 p.
 artikel
60 PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia Giles, Francis J.
 2007
 31 Supplement 3 p. 891-897
7 p.
 artikel
61 P122 Value of transfusion-free living in myelodysplastic syndromes (MDS): results of health utility interviews with patients Goss, T.F.
 2007
 31 Supplement 3 p. S105-S106
2 p.
 artikel
62 Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia Spanaki, A.
 2007
 31 Supplement 3 p. 639-642
4 p.
 artikel
63 9 Refractory anemia with ringed sideroblasts Cazzola, M.
 2007
 31 Supplement 3 p. S6-
1 p.
 artikel
64 S06 Clinical relevance and treatment of transfusional iron overload in myelodysplastic syndromes Malcovati, L.
 2007
 31 Supplement 3 p. S116-
1 p.
 artikel
65 Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells Kimura, Noriko
 2007
 31 Supplement 3 p. 1529-1535
7 p.
 artikel
66 6 The immune pathophysiology of bone marrow failure and the emergence of clonal hematologic diseases Young, N.S.
 2007
 31 Supplement 3 p. S4-
1 p.
 artikel
67 3 Therapy-related myelodysplasia Pedersen-Bjergaard, J.
 2007
 31 Supplement 3 p. S1-S3
3 p.
 artikel
68 The spectrum of myelodysplastic syndromes post-solid organ transplantation: A single institutional experience Menes, M.
 2007
 31 Supplement 3 p. 59-65
7 p.
 artikel
69 Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence Shide, Kotaro
 2007
 31 Supplement 3 p. 1077-1084
8 p.
 artikel
70 Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia Yetgin, Sevgi
 2007
 31 Supplement 3 p. 493-496
4 p.
 artikel
71 36 Which myelodysplastic syndromes patients are candidates for transplantation? de Witte, T.
 2007
 31 Supplement 3 p. S21-S22
2 p.
 artikel
72 WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders Michiels, Jan Jacques
 2007
 31 Supplement 3 p. 1031-1038
8 p.
 artikel
73 23 WPSS, a dynamic prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes Malcovati, L.
 2007
 31 Supplement 3 p. S13-S14
2 p.
 artikel
74 XIAP is upregulated in HL-60 cells cocultured with stromal cells by direct cell contact Wang, Xiaofang
 2007
 31 Supplement 3 p. 1125-1129
5 p.
 artikel
                             74 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland